BioIVT to host emerging technologies in diagnostics symposium

BioIVT will be hosting a virtual Emerging Technologies in Diagnostics Symposium on  Thursday, October 29 (10am-1pm ET).

“The diagnostic assay landscape is changing rapidly as the demand for faster, less expensive, more precise diagnostics continues to grow,” said Cathie Miller, Director of Product Marketing, Personalised Medicine at BioIVT. “We wanted to take this opportunity to showcase some of the exciting new technologies that are helping to accelerate in vitro and companion diagnostic development. This event also reflects BioIVT’s commitment to helping bring effective diagnostics to market faster to improve human and animal health.”

Dr Miller will introduce three guest speakers and describe the integral role that BioIVT’s biological specimens and specialty research services are playing in the development of new diagnostic assays.

Rafiq Islam, MS, Regional Vice President, Pharmaceutical Development Services, at Smithers, will lead the first technical session, discussing bioanalytical method validation for biomarkers and companion diagnostics.

He will be followed by Kevin Kohlmeier, BS, Director of Marketing at IndevR, who will address rapid vaccine analysis. InDevR’s VaxArray Platform has been shown to speed vaccine analysis, improve data quality, eliminate assay development, and standardise assays used for vaccine testing.

Heather Tomlinson, PhD, director of clinical diagnostics at Promega Corporation, will discuss how the company used an established, on-market, PCR-based microsatellite instability assay to develop OncoMate MSI, its companion diagnostic for immune checkpoint inhibitors for all solid tumours regardless of their site of origin.

Dr Miller will also describe how BioIVT is able to provide high quality, ethically sourced biospecimens, representing a wide range of diseases and health conditions, to accelerate the development of diagnostic assays, companion diagnostics, and point-of-care devices. They include board certified, pathologist reviewed, ASTERAND human tissue samples, KEYSTONE Bulk control and calibrator plasma and other biofluids from specific donor cohorts.

Interested parties can register for this free online event here

Image credit: Austin Distil

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free